Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Albert

Showing results (421-430 of 438) with videos related to

Pageof 44
Sort By:
Journal of Human Immunity|October 27, 2025
Improved outcome of HSCT in STAT1 gain-of-function disease following JAK inhibition bridgingEmilie Pauline Buddingh, Mary Slatter, Juan Carlos Aldave Becerra, et al.
Ecology Letters|September 30, 2015
A global meta-analysis of the relative extent of intraspecific trait variation in plant communitiesAndrew Siefert, Cyrille Violle, Loïc Chalmandrier, et al.
The Journal of Allergy and Clinical Immunology|April 11, 2017
Outcome of hematopoietic cell transplantation for DNA double-strand break repair disordersJames Slack, Michael H Albert, Dmitry Balashov, et al.
The Journal of Allergy and Clinical Immunology|May 27, 2026
Guidance on JAK inhibitor treatment for inborn errors of JAK-STAT signaling (2026). An international consensus statement on behalf of the ESID/EBMT-IEWP and ERN-RITAPeter Olbrich, M Fischer, A Deyà-Martinez, et al.
The Journal of Allergy and Clinical Immunology. in Practice|November 5, 2018
Hematopoietic Stem Cell Transplantation as Treatment for Patients with DOCK8 DeficiencySusanne E Aydin, Alexandra F Freeman, Waleed Al-Herz, et al.
Nature Medicine|October 8, 2021
Clinical evolution, genetic landscape and trajectories of clonal hematopoiesis in SAMD9/SAMD9L syndromesSushree S Sahoo, Victor B Pastor, Charnise Goodings, et al.
Nature Medicine|November 20, 2021
Publisher Correction: Clinical evolution, genetic landscape and trajectories of clonal hematopoiesis in SAMD9/SAMD9L syndromesSushree S Sahoo, Victor B Pastor, Charnise Goodings, et al.
The Journal of Allergy and Clinical Immunology|October 31, 2021
Hematopoietic cell transplantation in severe combined immunodeficiency: The SCETIDE 2006-2014 European cohortArjan C Lankester, Benedicte Neven, Nizar Mahlaoui, et al.
Blood|April 5, 2024
Wiskott-Aldrich syndrome: a study of 577 patients defines the genotype as a biomarker for disease severity and survivalTanja C Vallée, Jannik S Glasmacher, Hannes Buchner, et al.
The Journal of Allergy and Clinical Immunology|November 7, 2023
JAK inhibitor treatment for inborn errors of JAK/STAT signaling: An ESID/EBMT-IEWP retrospective studyMarco Fischer, Peter Olbrich, Jérôme Hadjadj, et al.
Pageof 44

Showing results (421-430 of 438) with videos related to

Sort By:
Pageof 44
Journal of Human Immunity|October 27, 2025
Improved outcome of HSCT in STAT1 gain-of-function disease following JAK inhibition bridgingEmilie Pauline Buddingh, Mary Slatter, Juan Carlos Aldave Becerra, et al.
Ecology Letters|September 30, 2015
A global meta-analysis of the relative extent of intraspecific trait variation in plant communitiesAndrew Siefert, Cyrille Violle, Loïc Chalmandrier, et al.
The Journal of Allergy and Clinical Immunology|April 11, 2017
Outcome of hematopoietic cell transplantation for DNA double-strand break repair disordersJames Slack, Michael H Albert, Dmitry Balashov, et al.
The Journal of Allergy and Clinical Immunology|May 27, 2026
Guidance on JAK inhibitor treatment for inborn errors of JAK-STAT signaling (2026). An international consensus statement on behalf of the ESID/EBMT-IEWP and ERN-RITAPeter Olbrich, M Fischer, A Deyà-Martinez, et al.
The Journal of Allergy and Clinical Immunology. in Practice|November 5, 2018
Hematopoietic Stem Cell Transplantation as Treatment for Patients with DOCK8 DeficiencySusanne E Aydin, Alexandra F Freeman, Waleed Al-Herz, et al.
Nature Medicine|October 8, 2021
Clinical evolution, genetic landscape and trajectories of clonal hematopoiesis in SAMD9/SAMD9L syndromesSushree S Sahoo, Victor B Pastor, Charnise Goodings, et al.
Nature Medicine|November 20, 2021
Publisher Correction: Clinical evolution, genetic landscape and trajectories of clonal hematopoiesis in SAMD9/SAMD9L syndromesSushree S Sahoo, Victor B Pastor, Charnise Goodings, et al.
The Journal of Allergy and Clinical Immunology|October 31, 2021
Hematopoietic cell transplantation in severe combined immunodeficiency: The SCETIDE 2006-2014 European cohortArjan C Lankester, Benedicte Neven, Nizar Mahlaoui, et al.
Blood|April 5, 2024
Wiskott-Aldrich syndrome: a study of 577 patients defines the genotype as a biomarker for disease severity and survivalTanja C Vallée, Jannik S Glasmacher, Hannes Buchner, et al.
The Journal of Allergy and Clinical Immunology|November 7, 2023
JAK inhibitor treatment for inborn errors of JAK/STAT signaling: An ESID/EBMT-IEWP retrospective studyMarco Fischer, Peter Olbrich, Jérôme Hadjadj, et al.
Pageof 44